Trident Ltd Q1 FY27 Results Analysis: PAT Jumps 13%, Towel Margins Collapse 830 bps

CompoundingAI Research Updated July 21, 2026 2 min read
Neutral

Trident Ltd's Q1 FY27 numbers came in mixed, with revenue of Rs. 1,786.83 Cr (+4.68% YoY) and PAT growth of +12.95% YoY. Here's a quick read of what worked, what to watch, and what management said.

Quick Details
Results dateJuly 21, 2026
QuarterQ1 FY 2026-2027
Revenue (Q1)Rs. 1,786.83 Cr (+4.68% YoY)
PAT (Q1)Rs. 158.09 Cr (+12.95% YoY)
EBITDA margin17.55% (-51 bps YoY)
EPS (Q1)Rs. 0.31 (+14.81% YoY)
Market capRs. 12,821.36 Cr
CMPRs. 25.14

Quarter Snapshot

Revenue grew 4.68% YoY to Rs.1,786.83 Cr with a sharp 9.45% QoQ recovery, and PAT rose 12.95% YoY. Yarn segment EBIT doubled YoY, but Towel margins collapsed 830 bps QoQ and Paper & Chemicals margins halved. Forex loss and raw material cost pressure were notable headwinds. No quantifiable management guidance was available to measure surprise.

Key Investment Insights

Key Positives

  • Revenue grew 4.68% YoY to Rs.1,786.83 Cr, with sharp 9.45% QoQ recovery from Q4 subdued levels.
  • EBITDA margin (management basis) improved 250 bps QoQ to 17.55%.
  • PAT grew 12.95% YoY to Rs.158.09 Cr.
  • Yarn segment EBIT nearly doubled YoY to Rs.145.83 Cr, with margin expanding 751 bps to 15.28%.
  • Bedsheets segment EBIT grew 83% QoQ and 10% YoY.
  • Finance costs declined 4.31% YoY and 6.89% QoQ, reflecting lower debt levels.
  • D&A fell 24.36% YoY, providing a structural tailwind to PBT.

Risk Factors

  • Towel segment EBIT margin collapsed from 13.57% in Q4 to 5.27% in Q1, despite flat revenue.
  • Paper & Chemicals EBIT margin fell sharply YoY from 28.23% to 17.62%, despite 14.45% revenue growth.
  • Forex loss of Rs.8.71 Cr vs gain of Rs.(2.88) Cr a year ago, a Rs.11.59 Cr swing.
  • Raw material cost growth of 7.33% YoY outpaced revenue growth of 4.68%.
  • CFO resigned with no successor announced.
Share on X · LinkedIn · WhatsApp

Disclaimer: This results analysis is published for educational and informational purposes only. It is not investment advice, not a recommendation to buy, sell or hold any security.

Powered by CompoundingAI — AI research platform for Indian stocks, every claim cited from primary filings

Login Now